Immunopathology of multiple sclerosis

Dendrou, Calliope A., Fugger, Lars, Friese, Manuel A.·2015·Nature Reviews Immunology

Cited by (1,003)

Items 801–900 of 1,003

  1. Exploring the depths of IgG4: insights into autoimmunity and novel treatments
    Selen Ünlü, Blanca G. Sánchez Navarro, Elif Çakan, Daniel Berchtold, Rafael Meleka Hanna, Seçil Vural, Atay Vural, Andreas Meisel, Miriam L. Fichtner · 2024 · Frontiers in Immunology
  2. A Comprehensive Examination of the Role of Epigenetic Factors in Multiple Sclerosis
    Ida Manna, Selene De Benedittis, Danilo Porro · 2024 · International Journal of Molecular Sciences
  3. Tele-exercise in multiple sclerosis: Systematic review and meta-analysis of effects on fatigue, depression, and overall health
    Parisa Najafi, Robert Wayne Motl, Mehrzad Moghadasi · 2024 · Multiple Sclerosis and Related Disorders
  4. Activated monocytes and markers of inflammation in newly diagnosed multiple sclerosis
    Mikkel Carstensen, Tove Christensen, Morten Stilund, Holger Jon Møller, Eva Lykke Petersen, Thor Petersen · 2020 · Immunology and Cell Biology
  5. Brain-homing CD4 + T cells display glucocorticoid-resistant features in MS
    Steven C. Koetzier, Jamie van Langelaar, Katelijn M. Blok, Thierry P. P. van den Bosch, Annet F. Wierenga‐Wolf, Marie‐José Melief, Kim Pol, Theodora A. M. Siepman, Georges M. G. M. Verjans, Joost Smolders et al. · 2020 · Neurology Neuroimmunology & Neuroinflammation
  6. A Gut Feeling: The Importance of the Intestinal Microbiota in Psychiatric Disorders
    Javier Ochoa‐Repáraz, Christina C. Ramelow, Lloyd H. Kasper · 2020 · Frontiers in Immunology
  7. Inhibition of lysophosphatidic acid receptor 1–3 deteriorates experimental autoimmune encephalomyelitis by inducing oxidative stress
    Jong Hee Choi, Jinhee Oh, Min Jung Lee, Hyunsu Bae, Seong‐Gyu Ko, Seung-Yeol Nah, Ik‐Hyun Cho · 2021 · Journal of Neuroinflammation
  8. Desired Resources for Changing Diet Among Persons With Multiple Sclerosis: Qualitative Inquiry Informing Future Dietary Interventions
    Stephanie L. Silveira, Emma V. Richardson, Robert Wayne Motl · 2021 · International Journal of MS Care
  9. B Cells in the CNS at Postmortem Are Associated With Worse Outcome and Cell Types in Multiple Sclerosis
    Marcello Moccia, Lukas Haider, Arman Eshaghi, Steven H. van de Pavert, Vincenzo Brescia Morra, Amy Patel, Claudia A. M. Gandini Wheeler‐Kingshott, Frederik Barkhof, Olga Ciccarelli · 2021 · Neurology Neuroimmunology & Neuroinflammation
  10. Therapeutic Potentials of Poly (ADP‐Ribose) Polymerase 1 (PARP1) Inhibition in Multiple Sclerosis and Animal Models: Concept Revisiting
    Yan Wang, David Pleasure, Wenbin Deng, Fuzheng Guo · 2021 · Advanced Science
  11. Contact-Dependent Granzyme B-Mediated Cytotoxicity of Th17-Polarized Cells Toward Human Oligodendrocytes
    Hélène Jamann, Qiao‐Ling Cui, Haritha L. Desu, Florian Pernin, Olivier Tastet, Alexandre Halaweh, Negar Farzam‐kia, Victoria Hannah Mamane, Oumarou Ouédraogo, Aurélie Cleret‐Buhot et al. · 2022 · Frontiers in Immunology
  12. NR4A1 agonist cytosporone B attenuates neuroinflammation in a mouse model of multiple sclerosis
    Limei Wang, Hai-Zhen Yu, Bing-Qing Zhu, Lin Dan Zhu, Shuo Li · 2022 · Neural Regeneration Research
  13. Innate Lymphoid Cells - Neglected Players in Multiple Sclerosis
    Negar Sadeghi Hassanabadi, Bieke Broux, Sonja Marinović, Dagmar Gotthardt · 2022 · Frontiers in Immunology
  14. Genetic risk variants for multiple sclerosis are linked to differences in alternative pre-mRNA splicing
    Elena Putscher, Michael Hecker, Brit Fitzner, Nina Boxberger, Margit Schwartz, Dirk Koczan, Peter Lorenz, Uwe Klaus Zettl · 2022 · Frontiers in Immunology
  15. Neuroprotective effects of bornyl acetate on experimental autoimmune encephalomyelitis via anti-inflammatory effects and maintaining blood-brain-barrier integrity
    Joon-Il Lee, Jonghee Choi, Tae-Woo Kwon, Hyo-Sung Jo, Do-Geun Kim, Seong‐Gyu Ko, Gyun Jee Song, Ik‐Hyun Cho · 2022 · Phytomedicine
  16. Is there a role for herpes simplex virus type 1 in multiple sclerosis?
    Luisa Fernanda Duarte, Sebastián Gatica, Almendra Castillo, Alexis M. Kalergis, Susan M. Bueno, Claudia A. Riedel, Pablo A. González · 2022 · Microbes and Infection
  17. Endothelial cell‐derived oxysterol ablation attenuates experimental autoimmune encephalomyelitis
    Florian Ruiz, Benjamin Peter, Jessica Rebeaud, Solenne Vigne, Valentine Bressoud, Martin Roumain, Tania Wyss, Yannick Yersin, Ingrid Wagner, Mario Kreutzfeldt et al. · 2023 · EMBO Reports
  18. Role of DAMPs and cell death in autoimmune diseases: the example of multiple sclerosis
    Walter Gottlieb Land · 2023 · Genes and Immunity
  19. High serum neurofilament light chain levels correlate with brain atrophy and physical disability in multiple sclerosis
    Arabella Buchmann, Lukas Pirpamer, Daniela Pinter, Margarete M. Voortman, Birgit Helmlinger, Alexander Pichler, Aleksandra Maleska Maceski, Pascal Benkert, Gerhard Bachmaier, Stefan Ropele et al. · 2023 · European Journal of Neurology
  20. Inter-assay diagnostic accuracy of cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis
    Cathérine Dekeyser, Pieter M. M. De Kesel, Melissa Cambron, Ludo J. Vanopdenbosch, Liesbeth Van Hijfte, Martine J. Vercammen, Guy Laureys · 2024 · Frontiers in Immunology
  21. Novel aspects of defensins’ involvement in virus-induced autoimmunity in the central nervous system
    Evangelos I. Kazakos, Jannis Kountouras, Stergios A. Pοlyzos, Georgia Deretzi · 2017 · Medical Hypotheses
  22. Multiple Sclerosis: Implications of Obesity in Neuroinflammation
    Ana Margarida Novo, Sónia Batista · 2017 · Advances in neurobiology
  23. Splitting the “Unsplittable”: Dissecting Resident and Infiltrating Macrophages in Experimental Autoimmune Encephalomyelitis
    Tobias Koeniger, Stefanie Küerten · 2017 · International Journal of Molecular Sciences
  24. Transcriptome profiling of peripheral blood immune cell populations in multiple sclerosis patients before and during treatment with a sphingosine‐1‐phosphate receptor modulator
    Ines Charlotte Angerer, Michael Hecker, Dirk Koczan, Luisa Roch, Jörg Friess, Annelen Rüge, Brit Fitzner, Nina Boxberger, Ina Schröder, Kristin Flechtner et al. · 2018 · CNS Neuroscience & Therapeutics
  25. A Kv1.3 channel‐specific blocker alleviates neurological impairment through inhibiting T‐cell activation in experimental autoimmune encephalomyelitis
    Xiaolu Yuan, Yipeng Zhao, Jie Huang, Jun‐Chen Liu, Wen‐Qian Mao, Jun Yin, Biwen Peng, WanHong Liu, Song Hee Han, Xiao‐Hua He · 2018 · CNS Neuroscience & Therapeutics
  26. Erythrocyte microRNA sequencing reveals differential expression in relapsing-remitting multiple sclerosis.
    Groen, Kira, Maltby, Vicki E., Lea, Rodney A., Sanders, Katherine A., Fink, J. Lynn, Scott, Rodney J., Tajouri, Lotti, Lechner-Scott, Jeannette · 2018 · BMC Medical Genomics
  27. Central nervous system‐infiltrated immune cells induce calcium increase in astrocytes via astroglial purinergic signaling
    Dunja D. Bijelić, Katarina D. Milicevic, Milica N. Lazarević, Djordje M. Miljković, Jelena Bogdanović Pristov, Danijela Z. Savić, Branka B. Petković, Pavle R. Anđjus, Miljana B. Momčilović, Ljiljana M. Nikolic · 2020 · Journal of Neuroscience Research
  28. What do we know about the role of lncRNAs in multiple sclerosis?
    Viviana Nociti, Massimo Santoro · 2021 · Neural Regeneration Research
  29. Metabolomics as a promising tool for improving understanding of multiple sclerosis: A review of recent advances
    Zhicheng Liu, Jeffrey Waters, Bin Rui · 2022 · Biomedical Journal
  30. Antibody cross-reactivity between casein and myelin-associated glycoprotein results in central nervous system demyelination
    Rittika Chunder, Alicia Weier, Hannah Mäurer, Nicolas Luber, Michael Enders, Gabriele Luber, Thorsten Heider, Alfred Spitzer, Sabine Tacke, Janine Becker-Gotot et al. · 2022 · Proceedings of the National Academy of Sciences
  31. The Role for Exosomal microRNAs in Disruption of Regulatory T Cell Homeostasis in Multiple Sclerosis
    Kimitoshi Kimura, Hirohiko Hohjoh, Takashi Yamamura · 2018 · Journal of Experimental Neuroscience
  32. Gene Therapy Approaches in an Autoimmune Demyelinating Disease: Multiple Sclerosis
    Islam, Md. Asiful, Kundu, Shoumik, Hassan, Rosline · 2020 · Current Gene Therapy
  33. A probiotic approach identifies a Treg-centred immunoregulation via modulation of gut microbiota metabolites in people with multiple sclerosis and healthy individuals
    Constantin Träger, Maria Kaiser, D. Freudenstein, Simon Heckscher, Katja Dettmer, Peter Josef Oefner, Gerhard Liebisch, Andreas Hiergeist, André Gessner, De-Hyung Lee et al. · 2025 · EBioMedicine
  34. The Na+/Ca2+ exchangers in demyelinating diseases
    Francesca Boscia, Valéria de Rosa, Mariarosaria Cammarota, Agnese Secondo, Anna Pannaccione, Lucio Annunziato · 2019 · Cell Calcium
  35. Asymptomatic Herpes Simplex Virus Type 1 Infection Causes an Earlier Onset and More Severe Experimental Autoimmune Encephalomyelitis
    Luisa Fernanda Duarte, María José Altamirano-Lagos, Jorge Humberto Tabares-Guevara, María Cecilia Opazo, Máximo Díaz, Romina Andino‐Navarrete, Catalina Muza, Omar P. Vallejos, Claudia A. Riedel, Susan M. Bueno et al. · 2021 · Frontiers in Immunology
  36. Social Cognitive Theory variables as correlates of physical activity in fatigued persons with multiple sclerosis
    Brenda Jeng, Katie L.J. Cederberg, Trinh L. T. Huynh, Petra Šilić, Catherine Danielle Jones, Corey D. Feasel, E. Morghen Sikes, Jessica F. Baird, Stephanie L. Silveira, Jeffer Eidi Sasaki et al. · 2021 · Multiple Sclerosis and Related Disorders
  37. Microbiota in Health and Disease—Potential Clinical Applications
    Matthias Laudes, Corinna Geisler, Nathalie Rohmann, Jildau Bouwman, Tobias Pischon, Kristina Schlicht · 2021 · Nutrients
  38. Immune signature of multiple sclerosis-associated depression
    Jelena Brasanac, Caren Ramien, Stefanie Gamradt, Aline Taenzer, Laura Glau, Kristin Ritter, Kostas Patas, Agorastos Agorastos, Klaus Wiedemann, Cüneyt Demiralay et al. · 2021 · Brain Behavior and Immunity
  39. Spermine alleviates experimental autoimmune encephalomyelitis via regulating T cell activation and differentiation
    Ruting Zheng, Miaomiao Kong, Siwei Wang, Bingqing He, Xin Xie · 2022 · International Immunopharmacology
  40. Neuroprotective Potential of Dendritic Cells and Sirtuins in Multiple Sclerosis
    Francesco Piacente, Marta Bottero, Andrea Benzi, Tiziana Vigo, Antonio Uccelli, Santina Bruzzone, Giovanni Battista Ferrara · 2022 · International Journal of Molecular Sciences
  41. Cathelicidin‐related antimicrobial peptide promotes neuroinflammation through astrocyte–microglia communication in experimental autoimmune encephalomyelitis
    Anup Bhusal, Youngpyo Nam, Donggun Seo, Md Habibur Rahman, Eun Mi Hwang, Seung‐Chan Kim, Won‐Ha Lee, Kyoungho Suk · 2022 · Glia
  42. Detecting ongoing disease activity in mildly affected multiple sclerosis patients under first-line therapies
    Lars Masanneck, Leoni Rolfes, Liesa Regner-Nelke, Alice Willison, Saskia Jania Räuber, Falk Steffen, Stefan Bittner, Frauke Zipp, Philipp Albrecht, Tobias Ruck et al. · 2022 · Multiple Sclerosis and Related Disorders
  43. Multiple sclerosis and circadian rhythms: Can diet act as a treatment?
    Olga Pivovarova‐Ramich, Hanna Gwendolyn Zimmermann, Friedemann Paul · 2023 · Acta Physiologica
  44. The role of the gut microbiota and fecal microbiota transplantation in neuroimmune diseases
    Nan Wu, Xizhi Li, He Ma, Xue Zhang, Bin Liu, Wang Yuan, Qi Zheng, Xueli Fan · 2023 · Frontiers in Neurology
  45. Choroid Plexus Volume Change—A Candidate for a New Radiological Marker of MS Progression
    Anna Jankowska, Kamil Chwojnicki, Małgorzata Grzywińska, Piotr Trzonkowski, Edyta Szurowska · 2023 · Diagnostics
  46. B cell depletion attenuates CD27 signaling of T helper cells in multiple sclerosis
    Can Ulutekin, Edoardo Galli, Bettina Schreiner, Mohsen Khademi, Ilaria Callegari, Fredrik Piehl, Nicholas Sanderson, Daniel Kirschenbaum, Sarah Mundt, Massimo Filippi et al. · 2023 · Cell Reports Medicine
  47. Angiogenic factors are associated with multiple sclerosis
    Sajad Karampoor, Hamid Zahednasab, Sreeram V Ramagopalan, Masoud Mehrpour, Hossein Keyvani · 2016 · Journal of Neuroimmunology
  48. Spatial and molecular changes of mouse brain metabolism in response to immunomodulatory treatment with teriflunomide as visualized by MALDI-MSI
    Ignacy Rzagalinski, Nadine Hainz, Carola Meier, Thomas Tschernig, Dietrich A. Volmer · 2018 · Analytical and Bioanalytical Chemistry
  49. Acid sensing ion channel 2: A new potential player in the pathophysiology of multiple sclerosis
    Teresa Fazia, Roberta Pastorino, Serena Notartomaso, Carla Letizia Busceti, Tiziana Imbriglio, Milena Cannella, Davide Gentilini, Gabriele Morani, Anna Ticca, Pierpaolo Bitti et al. · 2018 · European Journal of Neuroscience
  50. Long-term follow-up of multiple sclerosis studies and outcomes from early treatment of clinically isolated syndrome in the BENEFIT 11 study
    Hans‐Peter Hartung, Jonas Graf, David Kremer · 2019 · Journal of Neurology
  51. Comparing the Convergent and Concurrent Validity of the Dynamic Gait Index with the Berg Balance Scale in People with Multiple Sclerosis
    Tapan S. Mehta, Hui‐Ju Young, Byron W. Lai, Fuchenchu Wang, Yumi Kim, Mohanraj Thirumalai, Tracy Tracy, Robert Wayne Motl, James Howard Rimmer · 2019 · Healthcare
  52. 18F-FAC PET Visualizes Brain-Infiltrating Leukocytes in a Mouse Model of Multiple Sclerosis
    Bao Ying Chen, Chiara Ghezzi, Brendon Villegas, Andrew S. W. Quon, Caius G. Radu, Owen N. Witte, Peter M. Clark · 2019 · Journal of Nuclear Medicine
  53. The priorities of neurologists for exercise promotion in comprehensive multiple sclerosis care
    Emma V. Richardson, Matthew M. Fifolt, Elizabeth A. Barstow, Stephanie L. Silveira, E. Morghen Sikes, Robert Wayne Motl · 2019 · Multiple Sclerosis and Related Disorders
  54. Experimental Models of Neuroimmunological Disorders: A Review
    Ana Paula Bornes da Silva, Rodrigo Braccini Madeira Silva, Leise Daniele Sckenal Goi, Rachel Dias Molina, Denise Cantarelli Machado, Douglas Kazutoshi Sato · 2020 · Frontiers in Neurology
  55. Cerebrospinal fluid draining lymphatics in health and disease: advances and controversies
    Donald M. McDonald, Kari K. Alitalo, Christer Betsholtz, Britta Engelhardt, Steven T. Proulx, Julie A. Siegenthaler, Gou Young Koh · 2025 · Nature Cardiovascular Research
  56. Targeting the RNA-Binding Protein HuR Alleviates Neuroinflammation in Experimental Autoimmune Encephalomyelitis: Potential Therapy for Multiple Sclerosis
    Vittoria Borgonetti, Maria Domenica Sanna, Laura Lucarini, Nicoletta Galeotti · 2020 · Neurotherapeutics
  57. Computational modeling of the immune response in multiple sclerosis using epimod framework
    Simone Pernice, Laura Follia, Alessandro Maglione, Marzio Alfio Pennisi, Francesco Pappalardo, Francesco Novelli, Marinella Clerico, Marco Beccuti, Francesca Cordero, Simona Rolla · 2020 · BMC Bioinformatics
  58. Current Immunological and Clinical Perspective on Vaccinations in Multiple Sclerosis Patients: Are They Safe after All?
    Shani Witman Tsur, Eli Adrian Zaher, Meydan Tsur, Karolina Kania, Alicja Kalinowska · 2021 · International Journal of Molecular Sciences
  59. Real-Life Experience of the Effects of Cladribine Tablets on Lymphocyte Subsets and Serum Neurofilament Light Chain Levels in Relapsing Multiple Sclerosis Patients
    Damiano Paolicelli, Maddalena Ruggieri, Alessia Manni, Concetta Domenica Gargano, Graziana Carleo, Claudia Palazzo, Antonio Iaffaldano, Luca Bollo, Tommaso Guerra, Annalisa Saracino et al. · 2022 · Brain Sciences
  60. IFN-γR/STAT1 signaling in recipient hematopoietic antigen-presenting cells suppresses graft-versus-host disease
    Caisheng Lu, Huihui Ma, Liangsong Song, Hui Wang, Lily Hui-Ching Wang, Shirong Li, Stephen M. Lagana, Antonia R. Sepulveda, Kasper H. N. Hoebe, Samuel S. Pan et al. · 2022 · Journal of Clinical Investigation
  61. Shared Genetic Risk Factors for Multiple Sclerosis /Psoriasis Suggest Involvement of Interleukin‐17 and Janus Kinase–Signal Transducers and Activators of Transcription Signaling
    Matthew T. Patrick, Rajan P. Nair, Kevin He, Philip E. Stuart, Allison C. Billi, Xiang Zhou, Johann Eli Gudjonsson, Jorge R. Oksenberg, James T. Elder, Lam C. Tsoi · 2023 · Annals of Neurology
  62. Sequential treatment with a TNFR2 agonist and a TNFR1 antagonist improves outcomes in a humanized mouse model for MS
    Valentina Pegoretti, Jan Bauer, Roman Fischer, Iskra Paro, Wanda Douwenga, Roland E. Kontermann, Klaus Pfizenmaier, Evelien Houben, Bieke Broux, Niels Hellings et al. · 2023 · Journal of Neuroinflammation
  63. Effect of different types of exercise on fitness in people with multiple sclerosis: A network meta‐analysis
    Sara Reina‐Gutiérrez, A.B. Meseguer-Henarejos, Ana Isabel Torres-Costoso, Celia Álvarez‐Bueno, Iván Cavero‐Redondo, Sergio Núñez de Arenas‐Arroyo, María José Guzmán‐Pavón, Mairena Sánchez‐López, Vicente Martínez‐Vizcaíno · 2023 · Scandinavian Journal of Medicine and Science in Sports
  64. Central and peripheral myeloid-derived suppressor cell-like cells are closely related to the clinical severity of multiple sclerosis
    María Cristina Ortega, Rafael Lebrón‐Galán, Isabel Machín-Díaz, Michelle Naughton, Inmaculada Pérez-Molina, Jennifer García-Arocha, José Manuel García‐Domínguez, Haydee Goicoechea-Briceño, Virginia Vila‐del Sol, Víctor Quintanero-Casero et al. · 2023 · Acta Neuropathologica
  65. In silico analysis of RPS4X (X-linked ribosomal protein) with active components from black seed (Nigella sativa) for potential treatment of multiple sclerosis
    Mouhamed Zakiou Kolawole Adissa Raimi, Aneeqa Nadeem, Kayode Yomi Raheem, Ghulam Hussain, Nousheen Zafeer, Mamoudou Hamadou, Muhammad Irfan, Jairus Olumasai Nandwa, Faheem Ahmad, Anwar Ullah et al. · 2023 · Journal of Molecular Structure
  66. Discovery of a brain-permeable bromodomain and extra terminal domain (BET) inhibitor with selectivity for BD1 for the treatment of multiple sclerosis
    Xuetao Chen, Tingting Wu, Zhiyan Du, Wenjing Kang, Rujun Xu, Fanying Meng, Chihong Liu, Yali Chen, Qichao Bao, Jingkang Shen et al. · 2023 · European Journal of Medicinal Chemistry
  67. Anti‐ and pro‐inflammatory milieu differentially regulate differentiation and immune functions of oligodendrocyte progenitor cells
    Omri Zveik, Ariel Rechtman, Livnat Brill, Adi Vaknin‐Dembinsky · 2024 · Immunology
  68. Astrocytic crosstalk with brain and immune cells in healthy and diseased conditions
    Se Young Lee, Won‐Suk Chung · 2024 · Current Opinion in Neurobiology
  69. A thermosensitive chitosan hydrogel: An attempt for the nasal delivery of dimethyl fumarate
    Noelia Nieto González, Giovanna Rassu, Massimo Cossu, Laura Catenacci, Milena Sorrenti, Eleonora Sofia Cama, Carla Serri, Paolo Giunchedi, Elisabetta Gavini · 2024 · International Journal of Biological Macromolecules
  70. Maresin-1 promotes neuroprotection and modulates metabolic and inflammatory responses in disease-associated cell types in preclinical models of multiple sclerosis
    Insha Zahoor, Mohammad Nematullah, Mohammad Ejaz Ahmed, Mena Fatma, Mir Sajad, Kamesh Ayasolla, Mirela Cerghet, Suresh S. Palaniyandi, Veronica Ceci, Giulia Carrera et al. · 2025 · Journal of Biological Chemistry
  71. Relevance of antiphospholipid antibodies in multiple sclerosis: A systematic review and meta analysis
    Mira Merashli, José Delgado Alves, Fabrizio Gentile, Paul R. J. Ames · 2016 · Seminars in Arthritis and Rheumatism
  72. High Dimensional Cytometry of Central Nervous System Leukocytes During Neuroinflammation
    Dunja Mrdjen, Felix J. Hartmann, Burkhard Becher · 2017 · Methods in molecular biology
  73. Insights into the Role of Neuroinflammation in the Pathogenesis of Multiple Sclerosis
    Ghaith Al‐Badri, Alessandro Castorina · 2018 · Journal of Functional Morphology and Kinesiology
  74. Coexistence of systemic lupus erythematosus and multiple sclerosis. A case report and literature review
    Elisa Carolina Jácome Sánchez, María Ariana García Castillo, Víctor Ezequiel Paredes-González, Fernando Guillén López, Edgar Patricio Correa Díaz · 2018 · Multiple Sclerosis Journal - Experimental Translational and Clinical
  75. Increased CCL18 plasma levels are associated with neurodegenerative MRI outcomes in multiple sclerosis patients
    Nicole Ziliotto, Francesco Bernardi, Dejan Jakimovski, Marcello Baroni, Niels Bergsland, Deepa Preeti Ramasamy, Bianca Weinstock‐Guttman, Paolo Zamboni, Giovanna Marchetti, Robert Zivadinov et al. · 2018 · Multiple Sclerosis and Related Disorders
  76. What can characterization of cerebrospinal fluid escape populations teach us about viral reservoirs in the central nervous system?
    Sarah Joseph, Mattia Trunfio, Laura Pesci Kincer, Andrea Calcagno, Richard W. Price · 2019 · AIDS
  77. Assessment of Mitochondrial Dysfunction in Experimental Autoimmune Encephalomyelitis (EAE) Models of Multiple Sclerosis
    Xiulin Ng, Mona Sadeghian, Simon Heales, Iain Parry Hargreaves · 2019 · International Journal of Molecular Sciences
  78. Systemic inflammation moderates the association of prior concussion with hippocampal volume and episodic memory in high school and collegiate athletes
    Benjamin L. Brett, Jonathan B. Savitz, Morgan E. Nitta, Lezlie Y. España, T. Kent Teague, Lindsay D. Nelson, Michael McCrea, Timothy Bradley Meier · 2020 · Brain Behavior and Immunity
  79. Metabolic determinants of leukocyte pathogenicity in neurological diseases
    Marah C. Runtsch, Giovanni Battista Ferrara, Stefano Angiari · 2020 · Journal of Neurochemistry
  80. Evaluation of Thiol Homeostasis in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders
    Burak Arslan, Gökçe Ayhan Arslan, Aslı Tuncer, Rana Karabudak, Aylin Sepici Dinçel · 2021 · Frontiers in Neurology
  81. Gut Microbiota-Modulated Metabolomic Profiling Shapes the Etiology and Pathogenesis of Autoimmune Diseases
    Yi-Wen Tsai, Jia-Ling Dong, Yun-Jie Jian, Shin‐Huei Fu, Ming‐Wei Chien, Yuwen Liu, Chao-Yuan Hsu, Huey‐Kang Sytwu · 2021 · Microorganisms
  82. Inhalation of dimethyl fumarate-encapsulated solid lipid nanoparticles attenuate clinical signs of experimental autoimmune encephalomyelitis and pulmonary inflammatory dysfunction in mice
    Bárbara Fernandes Pinto, Lorena Natasha Brito Ribeiro, Gisela Bevilacqua Rolfsen Ferreira da Silva, Camila Simões de Freitas, Lucas Rocha Kraemer, Fabrício Marcus Silva Oliveira, Marianna de Carvalho Clímaco, Flávio Afonso Gonçalves Mourão, Gabryella S. P. Santos, Samantha Ribeiro Béla et al. · 2021 · Clinical Science
  83. Epidemiology of familial multiple sclerosis in Iran: a national registry-based study
    Zahra Salehi, Amir Almasi‐Hashiani, Mohammad Ali Sahraian, Fereshteh Ashtari, Seyed Mohammad Baghbanian, Nazanin Razazian, Abdorreza Naser Moghadasi, Asghar Bayati, Amir Reza Azimi, Nahid Beladimoghadam et al. · 2022 · BMC Neurology
  84. Sex-specific Tau methylation patterns and synaptic transcriptional alterations are associated with neural vulnerability during chronic neuroinflammation
    Alessandro Didonna, Ester Cantó, Hengameh Shams, Noriko Isobe, Chao Zhao, Stacy J. Caillier, Carlo Condello, Hana Yamate-Morgan, Seema Kaushalya Tiwari-Woodruff, Mohammad R. K. Mofrad et al. · 2019 · Journal of Autoimmunity
  85. A systematic review of aerobic and resistance exercise and inflammatory markers in people with multiple sclerosis
    Vicki L. Wong, Matthew R. Holahan · 2019 · Behavioural Pharmacology
  86. Complement activation in cerebrospinal fluid in clinically isolated syndrome and early stages of relapsing remitting multiple sclerosis
    Irene Håkansson, Jan Ernerudh, Magnus Vrethem, Charlotte Dahle, Kristina Nilsson Ekdahl · 2020 · Journal of Neuroimmunology
  87. Theoretical and Therapeutic Implications of the Spasticity-Plus Syndrome Model in Multiple Sclerosis
    Antonio Bruno, Ettore Dolcetti, Diego Centonze · 2022 · Frontiers in Neurology
  88. Immune Cell Contributors to the Female Sex Bias in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
    Nuria Álvarez‐Sánchez, Shannon E. Dunn · 2022 · Current topics in behavioral neurosciences
  89. High mobility group box 1 (HMGB1) inhibition attenuates lipopolysaccharide-induced cognitive dysfunction and sickness-like behavior in mice
    Devlina Ghosh, Aditi Singh, Alok Kumar, Neeraj Sinha · 2022 · Immunologic Research
  90. Mitochondria: how eminent in ageing and neurodegenerative disorders?
    Chia Bamshad, Nima Najafi-Ghalehlou, Zahra Pourmohammadi-Bejarpasi, Kazuo Tomita, Yoshikazu Kuwahara, Tomoaki Sato, Alireza Feizkhah, Amaneh Mohammadi Roushnadeh, Mehryar Habibi Roudkenar · 2022 · Human Cell
  91. Therapeutic effect of combination vitamin D3 and siponimod on remyelination and modulate microglia activation in cuprizone mouse model of multiple sclerosis
    Kholoud M. Al-Otaibi, Badrah Saeed Ali Alghamdi, Maryam A. Al-Ghamdi, Rasha Abdulrashed Mansouri, Ghulam Md Ashraf, Ulfat M. Omar · 2023 · Frontiers in Behavioral Neuroscience
  92. Targeting CD20 in multiple sclerosis — review of current treatment strategies
    Natalia Chmielewska, Janusz Szyndler · 2023 · Neurologia i Neurochirurgia Polska
  93. The role of exosomes in central nervous system tissue regeneration and repair
    Jingtao Wang, Lingyan Yang · 2023 · Biomedical Materials
  94. Targeting T-cell integrins in autoimmune and inflammatory diseases
    Aidan Kelly, Aideen Long · 2023 · Clinical & Experimental Immunology
  95. The Influence of Sex Hormones and X Chromosome in Immune Responses
    Nina Anesi, Charles‐Henry Miquel, Sophie Laffont, Jean‐Charles Guéry · 2023 · Current topics in microbiology and immunology
  96. Neurodegeneration and its potential markers in the diagnosing of secondary progressive multiple sclerosis. A review
    Aleksandra Pogoda-Wesołowska, Angela Dziedzic, Karina Maciak, Adam Stępień, Marta Dziaduch, Joanna Saluk · 2023 · Frontiers in Molecular Neuroscience
  97. Bioavailable central nervous system disease-modifying therapies for multiple sclerosis
    Hans‐Peter Hartung, Bruce Cree, Michael Harry Barnett, Sven Guenther Meuth, Amit Bar‐Or, Lawrence Steinman · 2023 · Frontiers in Immunology
  98. Causal relationship between multiple sclerosis and cortical structure: a Mendelian randomization study
    Dongren Sun, Rui Wang, Qin Du, Ying Zhang, Hongxi Chen, Ziyan Shi, Xiaofei Wang, Hongyu Zhou · 2024 · Journal of Translational Medicine
  99. Unraveling the Intricacies of OPG/RANKL/RANK Biology and Its Implications in Neurological Disorders—A Comprehensive Literature Review
    Chrisanne Freeman, Merlyn Diana A. S, A. S. Priscilla · 2024 · Molecular Neurobiology
  100. CD27 natural killer cell subsets play different roles during the pre-onset stage of experimental autoimmune encephalomyelitis
    Ming Gao, Yan Yang, Daling Li, Bingxia Ming, Huoying Chen, Yan Sun, Yifan Xiao, Lin Lai, Huijuan Zou, Yong X. Xu et al. · 2016 · Innate Immunity